RPE65 is the essential trans-cis isomerase of the classical retinoid (visual) cycle. Mutations in RPE65 give rise to severe retinal dystrophies, most of which are associated with loss of protein function and recessive inheritance. The only known exception is a c.1430G>A (D477G) mutation that gives rise to dominant retinitis pigmentosa with delayed onset and choroidal and macular involvement. Position 477 is distant from functionally critical regions of RPE65. Hence, the mechanism of D477G pathogenicity remains unclear, although protein misfolding and aggregation mechanisms have been suggested. We characterized a D477G knock-in mouse model which exhibited mild age-dependent changes in retinal structure and function. Immunoblot analysis of protein extracts from the eyes of these knock-in mice demonstrated the presence of ubiquitinated RPE65 and reduced RPE65 expression. We observed an accumulation of retinyl esters in the knock-in mice as well as a delay in rhodopsin regeneration kinetics and diminished electroretinography responses, indicative of RPE65 functional impairment induced by the D477G mutation in vivo. However, a cell line expressing D477G RPE65 revealed protein expression levels, cellular localization and retinoid isomerase activity comparable to cells expressing wild-type protein. Structural analysis of an RPE65 chimera suggested that the D477G mutation does not perturb protein folding or tertiary structure. Instead, the mutation generates an aggregation-prone surface that could induce cellular toxicity through abnormal complex formation as suggested by crystal packing analysis. These results indicate that a toxic gain-of-function induced by the D477G RPE65 substitution may play a role in the pathogenesis of this form of dominant retinitis pigmentosa.
Introduction
The retinoid (visual) cycle is an enzymatic pathway that regenerates visual chromophore in vertebrates. This metabolic cycle takes place mainly in the retinal pigment epithelium (RPE), a single layer of cells adjacent to the photoreceptor outer segments. Continuous regeneration of visual chromophore is critical for detection of light, and defects in the enzymes involved in the retinoid cycle often culminate in retinal dystrophy. One of the indispensable enzymes of the visual cycle is an RPE-specific protein known as RPE65, which is the retinoid isomerase that catalyzes cleavage and isomerization of all-trans-retinyl esters to form 11-cis-retinol (1) (2) (3) .
RPE65 is a 61 kDa protein bound to the endoplasmic reticulum (ER) membranes of the RPE that is highly conserved among vertebrates and belongs to the carotenoid cleavage oxygenase (CCO) enzyme family (4-7). To date, over 100 mutations in RPE65 have been implicated in Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP) (8) , and almost all of these are inherited in a recessive manner. However, an autosomal dominant form of RPE65-associated RP with choroidal involvement has also been identified (9, 10) . This novel form of RP arises from a missense mutation in exon 13 of RPE65 (c.1430G>A) that changes the amino acid residue encoded at position 477 from Asp to Gly (D477G).
Carriers of the D477G mutation exhibit varying phenotypes including disease severity and age of disease onset. They also display areas of retinal atrophy ranging from the choroid to the photoreceptor layer (9, 10) . Unlike typical RP patients who present with progressive visual field loss from the mid to far periphery, most carriers of the D477G mutation initially present with a central visual defect (10) . Moreover, choroidal atrophy and RPE hypertrophy are frequently observed and distinctive features associated with this mutation (9, 10) .
Previous studies of the RPE65 D477G mutation have suggested that the pathological phenotype is attributable to structural destabilization of RPE65 due to increased folding free energy (9) and delayed chromophore regeneration resulting from dominant-negative suppression of RPE65 retinoid isomerase activity (11) . However, visual cycle activity in heterozygous D477G knock-in (KI) mice can replenish sufficient 11-cis-retinaldehyde to support relatively normal retinal function (11) . The disease-associated phenotypes in homozygous KI mice have not been reported to date, so the precise classification of this point mutation remains unclear. Understanding the pathological consequences of this mutation is likely to aid in the development of treatment strategies for this and potentially other RPE65-associated dominant forms of RP. For example, dominant-negative or haploinsufficiency mechanisms would imply that RPE65 gene therapy may be of value to D477G subjects (12) whereas gain-of-function mechanisms would likely not be responsive to this intervention.
In this study, we assessed the phenotype of an independently-generated D477G mouse line in both the heterozygous and homozygous states using a combination of highresolution imaging, histology, electroretinography (ERG) and retinoid profile analyses. We further studied the consequences of this mutation at the molecular level with in vitro isomerization assays, RNA sequencing, immunoblotting of ubiquitinated RPE65 and X-ray crystallographic analyses. These comprehensive studies provide novel insights into the pathogenesis of the D477G mutation.
Results
The D477G mutation does not affect expression, subcellular localization and isomerization activity in vitro
To evaluate the intracellular localization and enzymatic function of RPE65 carrying the D477G mutation, we used retroviral transduction to generate two NIH3T3 cell lines that stably express either LRAT that generates substrate for the isomerase and human RPE65 (hRPE65) or LRAT and the hRPE65 D477G mutant. Immunoblotting analysis of the cell lines showed comparable expression levels of hRPE65 and the D477G mutant (Fig. 1A) , which differs from R91W, G244V and Y368H substitutions that cause decreased stability of RPE65 in vitro (13, 14) . Next, we examined whether the D477G mutant was properly localized within NIH3T3 cells. Immunofluorescence confocal microscopy revealed that hRPE65 co-localized with the ER marker calnexin, consistent with previous reports (4, 5, 15) (Fig. 1B) . This localization was unchanged for D477G RPE65 suggesting the mutation does not affect protein trafficking or membrane association in this heterologous expression system (Fig. 1B) . Our results cannot definitively exclude the possibility that protein is misfolded and retained in the ER. However, it would be expected that such a protein would be quickly degraded. Moreover, previous work has shown that aggregates of mutant RPE65 including L22P, T101I and L408P point mutants exhibited punctate-like inclusion bodies whereas wild-type (WT) RPE65 exhibited a homogenous ER distribution (16) . Next, we assessed whether the D477G mutation changes RPE65 isomerization activity by incubating the NIH3T3 cell lines stably expressing LRAT and the D477G mutant or WT RPE65 protein with 10 mM all-trans-retinol for 16 h. Analysis of retinoids extracted from these cells revealed comparable production of 11-cis-retinol between the two cell lines (Fig. 1C-E ). These findings suggest that the D477G mutation does not affect ER localization and isomerization activity of RPE65 in cell culture assays.
mRNA from D477G RPE65 and ubiquitination of RPE65 induced by the D477G mutation
We generated D477G RPE65 KI mice by replacing the endogenous RPE65 gene with a targeting vector including exons 8-14 along with the D477G mutation ( Fig. 2A) . A neomycin (Neo) cassette flanked by Flp-recombinase target (FRT) sites was used for clonal selection and later excised by FLP recombinase expressed in the embryonic stem cells. The embryonic stem cells carrying the Neo deleted targeting vector were microinjected into C57Bl/ 6 blastocysts. The final KI allele contained the D477G mutation with one 85-bp FRT site remaining between exons 13 and 14. A primer set flanking the FRT site was used to distinguish the WT allele and mutant allele. WT mice had a 495-bp PCR product, whereas homozygous mice had a 580-bp PCR product; heterozygous mice had both PCR products (Fig. 2B) . Additional sequencing of cDNA from the heterozygous mice showed transcription of both WT and D477G mRNA (Fig. 2C) .
Next, we examined whether the D477G mutation affected the transcriptional level of RPE65 using real-time PCR. RPE65 mRNA levels were comparable between WT, heterozygous and homozygous KI mice (Supplementary Material, Fig. S1 ) consistent with prior data (11) . To evaluate the ratio of transcribed WT and D477G mRNA, we collected 95 RPE65 cDNA clones from the RPE layer of heterozygous mice and sequenced them.
Importantly, the number of D477G clones was 3.75-fold less than that of WT clones (Table 1) . We note that small differences in the mRNA secondary structure arising from the single nucleotide change could potentially bias the outcome of RT-PCR for the mutant transcript.
Next, we examined whether the D477G mutation affects translation or susceptibility of the protein to degradation. Immunoblotting of RPE lysates revealed that levels of RPE65 expression were decreased in heterozygous and to a greater extent in homozygous KI mice (Fig. 3A) . Previous studies have shown degradation of RPE65 mutants via the ubiquitin-proteasome pathway in vitro and in vivo (17) (18) (19) . To examine possible ubiquitination of RPE65 induced by the D477G substitution, we immunoprecipitated ubiquitinated proteins and then probed for the presence of RPE65 by immunoblotting. Lysates from WT mice did not exhibit ubiquitinated RPE65, whereas lysates from heterozygous and homozygous KI mice showed two distinct bands of increased molecular weight (Fig. 3B ). These findings suggest that the D477G mutation facilitated mono-and di-ubiquitination of RPE65 in vivo.
Changes in retinal morphology associated with the D477G mutation
To assess the consequences of the D477G mutation on retinal morphology, we compared WT, heterozygous and homozygous KI mice at different ages ranging from 3 to 9 months. First, we used scanning laser ophthalmoscopy (SLO) with an excitation wavelength of 490 nm and an emission filter of 500-700 nm to visualize the retinal fundus. Autofluorescent spots were present in 9-month-old heterozygous and 6-month-old homozygous KI mice (Fig. 4) . No such spots were observed in age-matched WT mice. This may represent inflammatory responses in the retina through activation of Mü ller cells, macrophages or microglia cells which were observed in several animal models displaying retinal degeneration (20) (21) (22) (23) . Next, we performed optical coherence tomography (OCT) imaging to visualize the retina in cross-section allowing us to determine whether the D477G mutation leads to retinal degeneration. A subtle reduction in outer nuclear layer (ONL) thickness was observed in 6-month-old heterozygous and homozygous KI mice and this thinning became more prominent in 9-monthold heterozygous and homozygous KI mice compared with agematched WT mice ( Fig. 5A and B) . Taken together, these results indicate the D477G mutation is associated with a slow degeneration that becomes more evident with aging. This finding is consistent with the phenotype observed in human patients harboring the same mutation.
Reduction in scotopic ERG responses associated with the D477G mutation A previous study of the D477G mutation reported that rod ERG responses in patients harboring the mutation were impaired, even in individuals with mild structural abnormalities (9) . To determine whether D477G affects the functional integrity of mouse retina and the rod photoreceptors in particular, we performed dark-adapted (scotopic) ERG recordings in both heterozygous and homozygous KI mice at 3, 6 and 9 months of age. ERG analysis in mice did not reveal a significant difference in aand b-wave amplitudes between WT, heterozygous and homozygous KI mice up to 6-months of age. However, at 9-months of age, scotopic a-and b-wave responses in both heterozygous and homozygous KI mice declined compared with the corresponding responses in WT mice ( Fig. S2B ). This result is consistent with the progressive thinning of the ONL in heterozygous and homozygous KI mice observed by OCT imaging and the later age of onset in humans with the D477G mutation compared with those with RPE65-associated recessive RP.
Impact of the D477G mutation on the mouse retinoid cycle regeneration (18, 24, 25) . Therefore, we examined whether the D477G mutation perturbs the visual cycle. We analyzed the retinoid composition in dark-adapted WT, heterozygous and homozygous KI mice at different ages ranging from 1 to 3 months. The amount of 11-cis-retinal in heterozygous and homozygous KI mice did not differ from WT mice, whereas the amount of retinyl esters in heterozygous and homozygous KI mice was higher than that in WT mice (Fig. 7A-C) . This elevated level of retinyl esters could be due to a feedback response to aberrant mutant protein. RPE65 could also play a role in retinyl ester mobilization from lipid droplet stores (retinosomes) (26, 27) outside of its role in cleaving and isomerizing retinyl esters for visual chromophore production as recently suggested (28) . Next, we examined the amount of 11-cis-retinal in WT, heterozygous and homozygous KI mice dark adapted for 4, 8, 12 and 20 h following a 10 min bleach. Compared with WT mice, homozygous KI mice had significantly lower amounts of 11-cisretinal after 4 and 8 h of dark adaptation; however, the amounts became comparable with those of WT mice after 20 h of dark adaptation (Fig. 7D ). Heterozygous KI mice had significantly lower amounts of 11-cis-retinal after 4 h of dark adaptation, but levels became comparable with WT mice at 8 h of dark adaptation. This result was further supported by the elevated quantity of retinyl esters found in homozygous (and at some time points, heterozygous) KI mice (Fig. 7E) . Additionally, we assessed the regeneration of 11-cis-retinal with the shorter dark-adaption period. WT, heterozygous and homozygous KI mice were exposed to a 10 min bleach, followed by dark adaptation for 10 min. As mice at 3, 6 and 9 months of age. Autofluorescent spots were first noted in 9-month-old heterozygous and 6-month-old homozygous KI mice fundus images, whereas such spots were scarcely visible in the WT/WT fundus.
expected, levels of 11-cis-retinal were lower in heterozygous and homozygous mice compared to WT (Fig. 7F ). This result was further supported by the elevated levels of retinyl esters found in heterozygous and homozygous KI mice (Fig. 7G ). Taken together, this retinoid profile suggests the 11-cis-retinal regeneration rate was reduced in both heterozygous and homozygous KI mice.
Analysis of the D477 structural environment
To better understand the pathogenicity of the D477G substitution, we analyzed the structure of the region of the RPE65 sequence near this position. Asp is conserved at position 477 in RPE65 from primates to sea lamprey, consistent with an important role for this residue (Fig. 8A) . The ExAC database revealed no missense mutations at position 477 although a synonymous substitution was documented (29) . Interestingly, glycine is found at a position equivalent to position 477 of human RPE65 in some CCO enzymes including human BCO1 and BCO2 as well as Synechocystis ACO, indicating that Gly is tolerated for protein structure and function in the presence of a suitable surrounding sequence (Fig. 8A ). The D477-containing loop and nearby residues in the surrounding bÀstrands are relatively well conserved between RPE65 and ACO compared with the protein chains as a whole, which exhibited only $25% sequence identity. D477 occupies the n þ 2 position of a type-1 b-turn element found within a loop connecting strands 32 and 33 of the b-propeller fold (30) . Our inspection of known RPE65 crystal structures revealed a consistent secondary structure for this protein region with some rigid body variation in its overall position. This loop is located distant from the active site, does not contribute to the membrane binding surface of the enzyme and is not involved in formation of the conserved dimeric interface or any other protein-protein interaction preserved across known crystal structures of RPE65 ( Fig. 8B) (31, 32) . Hence, a critical structural or functional role for D477 is not obvious from its position within the context of the three-dimensional structure. However, bÀturns are known to exert pivotal roles in protein folding (33) and in protein-protein interactions (34) . Thus, the D477G substitution could perturb the normal structure of this bÀturn causing pathogenic protein misfolding as discussed previously (9, 11) . For example, a glycyl residue in the n þ 2 position of the bÀturn could promote switching to a type-II conformation (34), thereby promoting the above-mentioned effects. Indeed, inspection of PDB entries containing the "HPGA" sequence within a bÀturn motif revealed that most are in a type-II conformation (35) . bÀturns with an "HPGA" sequence were observed only in non-metazoan species and are less common than the turns comprised of "HPDA" and "RPGG" sequences found in RPE65 and ACO, respectively.
Design and expression of a chimeric ACO protein containing the D477 loop
To date, it has not proven feasible to crystallize recombinantly produced RPE65, hampering direct examination of amino acid substitution effects on RPE65 structure. To circumvent this difficulty, we exploited the high structural similarity between RPE65 and ACO near position 477 (Fig. 8C ) to design a chimeric protein in which residues 474-485 of RPE65 were replaced in the equivalent position of the ACO sequence (Fig. 8A) . We also swapped four other residues in the ACO sequence to their RPE65 counterparts to maintain important chemical interactions and avoid steric clashes (Fig. 8A ). We expressed this hybrid protein, referred to herein as "ACO/RPE65-477-loop," and its corresponding D477G mutant in E. coli using the procedure previously described for WT ACO (36) . The two hybrid proteins were expressed in the soluble fraction at levels comparable with WT ACO (Fig. 9A , left) and could also be purified by the same protocol with a similar yield as ACO ( ). The a-wave amplitude, which reflects the initial response of photoreceptors to a light stimulus, did not show significant difference between 3-month-old and 6-month-old WT/WT, WT/KI and KI/KI mice. However, at 9 months of age, both WT/KI and KI/KI mice displayed significant reduction in a-wave amplitudes compared with WT/WT mice (P < 0.01),
suggesting that the mutation may cause a delayed onset of pathological phenotype. (B) Likewise, the amplitudes of the scotopic b-wave, which reflects the response of downstream retinal neurons to photoreceptor stimulation, also began to decline in 9-month-old WT/KI and KI/KI mice compared with WT/WT mice (P < 0.05). (C) To specifically examine the cone function, the photopic a-and b-wave amplitudes were plotted as a function of light stimulus intensity (À0.7 to 2.3 log cdÁsÁm 2 ). Similar to the results of scotopic ERG, the photopic a-wave amplitude began to decline in 9-month-old WT/KI and KI/KI mice (P < 0.05). (D) The photopic b-wave amplitude was also reduced in 9-month-old WT/KI and KI/KI mice (P < 0.05). Different sets of animals were used for ERG recordings at each time point. n ¼ 4 for the WT/WT group, n ¼ 4 for the WT/KI group, n ¼ 4 for the KI/KI group. Data are shown as mean 6 S.E.M.
presented on RPE65 D477G expression and activity in mammalian cells (Fig. 1A and E ).
Crystallization and structural determination of the ACO/ RPE65 D477 chimera To directly examine the structural preservation of the D477 loop in RPE65 and the ACO/RPE65 chimera, we crystallized ACO/ RPE65-477 loop under the same conditions used for WT ACO (36) . The crystals diffracted X-rays to $2.5 Å resolution and were isomorphous to the previously reported orthorhombic crystal form of ACO with four monomers in the asymmetric unit (Table 2) (37). Inspection of the initial electron density maps revealed clear difference density for the substituted residues. Following refinement (Table 2) , we found the loop conformation to be nearly identical to that of RPE65 with an overall root-mean-square in fully dark-adapted wild-type, heterozygous and homozygous mice. n ¼ 6 for 1-month-old WT/WT group, n ¼ 8 for 1-month-old WT/KI group, n ¼ 4 for 1-month-old KI/KI group, n ¼ 4 for 3-month-old WT/WT group, n ¼ 4 for 3-month-old WT/KI group and n ¼ 3 for 3-month-old KI/KI group. * indicates P < 0.05. Data are shown as mean 6 S.E.M. (C) Amount of 11-cis-retinal in fully dark-adapted wild-type, heterozygous and homozygous mice. n ¼ 6 for 1-month-old WT/WT group, n ¼ 8 for 1-month-old WT/KI group, n ¼ 4 for 1-month-old KI/KI group, n ¼ 4 for 3-month-old WT/WT group, n ¼ 4 for 3-month-old WT/KI group and n ¼ 3 for 3-month-old KI/KI cis-retinal following a bleach (5000 lux light for 10 min) in 9-month-old wild-type, heterozygous and homozygous mice after 10 min of dark adaptation. n ¼ 3 for the WT/WT group, n ¼ 5 for the WT/KI group and n ¼ 3 for the KI/KI group. Data are shown as mean 6 S.E.M. (G) Levels of retinyl esters following a bleach (5000 lux light for 10 min) in 9-month-old wild-type, heterozygous and homozygous mice after 10 min of dark adaptation. n ¼ 3 for the WT/WT group, n ¼ 5 for the WT/KI group and n ¼ 3 for the KI/KI group. Data are shown as mean 6 S.E.M. 34  34  34  34  34  34  76  24  42 P difference (RMSD) of 0.56 Å for all atoms in the loop based on a global superposition of the two structures (Fig. 10A) . These results validated our use of ACO/RPE65-D477 loop to infer the structural consequences of the RPE65 D477G mutation.
Crystallization and structural determination of the ACO/ RPE65 D477G mutant Next, we crystallized the D477G chimera variant again under the same conditions used for WT ACO. Strikingly, this single amino acid change resulted in the formation of trigonal and monoclinic crystals unprecedented amongst prior ACO and RPE65 crystallographic studies. These crystals grew either alone or as polymorphs with both forms present in a single drop (Supplementary Material, Fig. S4 ), whereas the original orthorhombic crystals were not observed for the point mutant. The trigonal crystals diffracted X-rays anisotropically to $3.1 Å resolution and belonged to the rare space group P312 with two molecules in the asymmetric unit. The monoclinic crystals diffracted X-rays more isotropically to a resolution of $2.6 Å and belonged to space group C2, also with two molecules in the asymmetric unit (Table 2 ). Refined structures of these two crystal forms revealed the expected absence of an aspartic acid side chain at position 434 (equivalent to position 477 in RPE65). The overall structure of the D477G loop region was like that of the D477 chimera (main chain RMSD of 0.48-0.86 Å depending on the specific chain) with a few notable differences (Fig. 10B  and C) . Focusing on the monoclinic crystal form for which the electron density support was strongest, the D477G-containing bÀturn was found in both a type-I (chain A) and a type-II (chain B) conformation. This variability is not unexpected given the conflicting tendencies of the His residue in position "n" to favor a type-I conformation through hydrogen bonding with the amide nitrogen of residue 434 and the glycyl residue at the n þ 2 position allowing the flipped orientation of the 433-434 peptide bond characteristic of a type-II turn. Additionally, Leu436 was displaced by $0.5-1.4 Å , depending on the subunit, and the side chains for Glu437 and Glu440 adopted different rotameric conformations compared with the ACO/RPE65-D477 loop. The latter alterations are likely due to a difference in crystal packing as discussed below. In both crystal forms, the electron density corresponding to the D477 loop and surrounding residues was well resolved indicating that the D477G substitution does not structurally destabilize this loop region.
The D477G substitution causes a gain of protein-protein interaction potential for the 477 loop
Molecular packing in the D477G crystals differed in a striking way from that of the original ACO/RPE65-D477-loop protein.
Whereas the D477 loop was not involved in significant proteinprotein contacts in the former crystal form (Supplementary Material, Fig. S5 ), contacts involving this loop were integrally involved in the crystal packing of both new crystal forms (Fig. 11 ).
In the trigonal crystals, the D477G loop regions of the two monomers within the asymmetric unit engage in two nonequivalent protein-protein interactions with contact surface areas of 477 and 411 Å 2 involving predominantly van der Waals interactions with a few H-bonds and salt bridges ( Fig. 11A and B). The two interactions occur at roughly the same site of the ACO/RPE65-D477G molecule but are rotated by 180 with respect to each other and involve two distinct sets of residues. In the monoclinic crystals, the D477G loop regions of the two molecules in the asymmetric unit engage in two non-identical but similar protein-protein interactions with contact surface areas of 415 and 389 Å 2 ( Fig. 11C and D) . The two contact points are related by a slight rotation and involve similar sets of residues forming distinct combinations of van der Waals and polar/ionic interactions. In both crystal forms, these predominantly hydrophobic interactions involving the D477G loop are among the major contact points responsible for crystal formation. In all four cases, multiple van der Waals interactions formed between the G434 a carbon and interacting residues indicate that the absence of the Asp side chain at position 434 crucially enabled formation of the protein-protein contacts. The D477G substitution thus triggered a gain of protein-protein interaction potential by allowing the 477 loop to form contacts with diverse molecular surfaces.
Discussion
Until recently, RPE65-associated RP and LCA were only known to occur as recessive diseases with complete penetrance and generally early onset, typically progressing to legal blindness within the first or second decade of human life (38) . The discovery of a phenotypically distinct, dominant form of RPE65-associated RP linked to the D477G mutation with a different time course of disease and incomplete penetrance was thus surprising when it was reported (9) . The D477G mutation is qualitatively different from other pathogenic RPE65 mutations reported to date. Recessive RP-associated mutations are typically located in critical active site regions or at the interfaces of the beta propeller blades, which directly affect the catalytic activity, folding trajectory or tertiary structure stability of the enzyme (13) . By contrast, D477 is located in a solvent-exposed loop located away from functionally critical regions of the protein (Fig. 8B) . It is also striking that closely related RPE65 family members encode a Gly residue at a position in their protein chain equivalent to residue 477 in RPE65 (Fig. 8A) . Hence, the pathogenic mechanism of this missense mutation has remained mysterious, although it was previously proposed that the D477G substitution could result in protein misfolding and/or aggregation (9, 10) . In this report, we provide evidence that the D477G substitution does not induce a protein-folding defect, similarly sparing any significant perturbation of the three-dimensional structure and catalytic activity of the protein. Instead, we find that it changes the physiochemical properties of the D477-containing loop to produce an aggregation-prone surface capable of engaging in abnormal protein-protein interactions. This change in interaction potential was directly observed at high resolution with an ACO/RPE65 chimeric protein containing the D477 loop and surrounding residues of RPE65. forms. Among the possible interactions that could be altered in vivo, we observed that D477G RPE65 is subject to recognition by ubiquitin ligases, likely due to the increased hydrophobicity of the 477 loop imparted by loss of the negatively charged Asp side chain (Supplementary Material, Fig. S6 ). This interpretation is supported by previous studies demonstrating that hydrophobic surfaces with the potential to cause insolubility or aggregation are recognized by the Ubc6/Ubc7-containing ubiquitination complex (39) . Ubiquitination of RPE65 likely targets it for proteasomal degradation as reported previously for recessive RP-associated RPE65 mutations in vitro (17) . A similar phenomenon was also observed in R91W RPE65 KI mice, where mutant RPE65 was polyubiquitinated and subsequently degraded by the 26S proteasome (19) . We observed that the degree of ubiquitination and degeneration was more extensive in homozygous KI mice, consistent with the retinoid profile in such mice. Therefore, two copies of the mutant allele in homozygous KI mice exacerbated their phenotypes, which could be interpreted as the D477G allele being semi-dominant (40) . Besides the protein-associated effect, we also observed that the c.1430G>A point mutation reduces mRNA levels relative to WT RPE65 mRNA, suggesting a defect in RNA stability or processing (Fig. 12) . It remains possible that the reduction in D477G mRNA is a result of the remaining loxP site in the mutant allele. Nevertheless, total RPE65 mRNA levels were comparable between the three genotypes as observed previously (11) suggesting that reduced processing or stability of D477G mRNA can be compensated for by transcriptional upregulation. The reduced levels of RPE65 we and others have observed in D477G KI mice raise the possibility of haploinsufficiency being involved in the disease pathogenesis. Although a few studies have suggested the possibility of retinal disease in carriers of recessive RP-associated RPE65 alleles (16, 41) , others specifically looking at the potential presence of retinal disease in RPE65-null mutant carriers have consistently concluded that heterozygous loss of RPE65 function (pure haploinsufficiency) does not adversely affect visual function or retinal structure in a clinically meaningful way (42) (43) (44) . Likewise, P25L and R91W KI mice, which are models of mild and severe RP, respectively, do not exhibit abnormal visual phenotypes in marked contrast to the respective homozygous KI mice. Heterozygous RPE65 KO mouse retinal structure and function are also indistinguishable from WT mice (4). Thus, haploinsufficiency appears not to underlie the retinal structural and functional defects associated with the D477G mutation.
The potential pathogenic mechanisms mentioned in the preceding text help explain the phenotypes we and others (11) have observed in RPE65 D477G KI mice. These mice exhibit an overall visual cycle insufficiency manifested by ERG suppression in older mice, a delay in visual chromophore regeneration and the accumulation of retinyl esters in both heterozygous and homozygous mice. These phenotypes can be attributed to reduced levels of functional RPE65 in KI mice, likely due to a reduction in RPE65 protein levels resulting from its ubiquination and proteolytic degradation (Fig. 12 ) as well as a potential dominant-negative effect exerted by the D477G mutant on visual chromophore production which could suppress visual cycle activity to a pathogenic level (11) . Given that RPE65 is likely a dimeric protein in vivo (32), the dominant-negative effect could be explained by heterodimer formation between WT and D477G resulting in potential mislocalization and/or degradation of the dimeric complex, thus reducing WT protein function (Fig. 12) . Besides effects on visual cycle function, we also observed pathological autofluorescent bodies in the retinas of heterozygous and homozygous KI mice by SLO imaging. Although these structures cannot be definitively identified by SLO, prior studies on animal disease models including Palm À/À (20), E150K opsin (22) and ABCA4
À/À /Rdh8 À/À (23) mice indicate that autofluorescent bodies reflect the infiltration of phagocytic cells into the retina. In addition to this abnormality, we also observed a mild decrement in photoreceptor number in mice of both genotypes relative to WT controls by OCT imaging. This loss of photoreceptors could originate either from visual chromophore deficiency as described previously for RPE65-associated recessive RP or from a generalized RPE dysfunction that perturbs the ability of the RPE to support photoreceptor health (45) . The latter mechanism, which implicates a direct toxic effect of D477G RPE65 on the RPE, is suggested by RPE hypertrophy and choroidal atrophy observed in humans carrying the RPE65 D477G substitution (9,10). We note that the mild loss of photoreceptors in these KI mice cannot fully account for the observed decrease in ERG responses, which again points to visual cycle insufficiency in these animals. Although gain-of-function mutations affecting protein folding and aggregation are most frequently associated with the formation of intracellular fibrils and amyloid as in Alzheimer disease and systemic amyloidosis (46) , such mutations can also exert subtler effects on cellular homeostasis not involving formation of beta-amyloid or other beta-sheet rich aggregates (47, 48) . Recent studies on protein-chaperone interactions have suggested that potentially aggregation-prone regions of a protein are frequently protected by so-called "gatekeeper" residues present within the peptide sequence (48, 49) . These typically hydrophilic residues (Arg, Lys, Glu and Asp) interrupt regions of hydrophobicity and may also increase surface entropy at otherwise aggregation-prone sites of a protein. Our data suggest that D477 could serve such a role in RPE65, as the Gly replacement allows formation of predominantly hydrophobic contacts that would be prohibited by the negatively charged Asp side chain. Figure 12 . Schematic diagram showing a proposed pathogenic mechanism of RP resulting from the D477G RPE65 mutation. In the RPE of WT/WT mice, RPE65 is localized in the ER membrane following translation and contributes to the visual cycle by isomerizing all-trans-retinyl esters to form 11-cis-retinol. In RPE of WT/KI mice, mRNA from the D477G RPE65 allele is significantly reduced. The hydrophobic neomorphic surface of D477G RPE65 could produce aggregates in the cytoplasm and impair the ER localization of RPE65. Due to the possibility of dimerization between D477G and WT RPE65, the mutation could also result in mislocalization of WT RPE65 resulting in a dominant-negative effect as described previously for D477G KI mice. The aggregates are ubiquitinated and degraded by proteasomes.
Loss of a surface-exposed gatekeeper residue leading to the aggregation of properly folded protein molecules, as we suggest here for D477G RPE65, has previously been documented for the sickle-cell anemia-associated E6V substitution in hemoglobin (known as hemoglobin S), which predisposes the protein to abnormal oligomerization (50) . This mutation does not affect the secondary, tertiary or quaternary structures of hemoglobin at normal oxygen concentrations (51) . However, during hypoxia, the protein can form abnormal homo-oligomers that generate characteristic sickling of red blood cells. Individuals carrying one abnormal allele only exhibit symptoms of sickle-cell anemia in the presence of stressors such as severe hydration or high-intensity physical activity (52) (53) (54) . Considering the relatively mild phenotype in the D477G KI mouse model and the incomplete penetrance of D477G-associated disease in humans (9,10), the pathogenic mechanism of D477G conceivably requires extra factors such as environmental stressors and agerelated physiological changes as triggers.
The R36S mutation in cD crystallin also exhibits abnormal protein-protein interactions enabled by loss of a gatekeeper residue that leads to dominant ophthalmic disease in spite of preserved native tertiary structure of the mutant protein (55) . The R36S missense mutation results in the formation of a novel protein-protein interaction surface that allows crystallin to crystallize in the lens. Notably, the structure of the mutant protein was determined from an actual crystal extracted from the affected patient's lens, which showed that the site of mutation allowed formation of new, predominantly hydrophobic proteinprotein interactions (55) . Other crystallin mutants have also been shown to exhibit abnormal aggregation behavior but with preserved tertiary structures (56). While we do not present data that suggests the D477G promotes abnormal RPE65 homooligomerization, the same concept of abnormal hydrophobic interactions could be applicable to RPE65 heterotypic interactions within the cell. Indeed, the fact that RPE65 is relatively abundant within the RPE suggests that it could be present at sufficient levels to generate substantial cellular stress through binding to cellular components.
The D477G RPE65 KI mouse that we report here recapitulates some but not all features of the human disease. As mentioned above, additional stressors required for the full phenotypic expression of the disease that are experienced by humans but not mice in a well-controlled laboratory environment could underlie the differences in disease severity. Lack of a macula in mouse retina might be another key factor contributing to the phenotypic discrepancy between humans and mice. Several patients with the D477G mutation developed a dystrophy of the macula, which is the area of highest cone density (9, 10) . In addition, mouse RPE conceivably could tolerate the existence of mutant RPE65 and clear protein aggregation products more effectively than human RPE. Therefore, RPE cells or 3-D retinal organoids differentiated from human-induced pluripotent stem cells carrying the D477G RPE65 mutation could be alternative tools for future studies on the pathogenesis and treatment of this form of RP.
Materials and Methods

Animals
D477G KI mice were generated by the InGenious Targeting Laboratory (Ronkonkoma, NY). C57BL/6J WT mice (Jackson Laboratory, Bar Harbor, ME) were used for mating with D477G KI mice. Mice were housed at the animal resource center at Case sies. The Rd8 mutation in Crb1 was absent in the animals used for this study (57) .
Mutagenesis and stable transduction of NIH3T3 cell lines
An NIH3T3 cell line stably expressing LRAT was generated by a previously published protocol (58) . The retroviral expression vectors were generated by introducing EcoRI and NotI restriction sites at the ends of the hRPE65 coding sequence by PCR with the following primers: forward, 5 0 -TAGGAATTCATGTCTATCCA GGTTGAG-3 0 ; reverse, 5 0 -TAAGCGGCCGCTCAAGATTTTTTGAAC AG-3 0 . The modified hRPE65 cDNA was inserted into a pMX-IG retroviral vector provided by Dr. T. Kitamura from the University of Tokyo (59) . An internal ribosomal entry site (IRES) and enhanced green fluorescence protein (EGFP) were placed downstream of the hRPE65 coding region, allowing co-expression of hRPE65 and EGFP from the same mRNA. The hRPE65 (D477G) mutation was introduced by PCR amplification of the entire plasmid by using Phusion High Fidelity polymerase (New England Biolabs, Ipswich, MA). NIH3T3-LRAT-hRPE65 and NIH3T3-LRAT-hRPE65 (D477G) stable cell lines were generated by transduction of NIH3T3-LRAT cells with retrovirus collected from Phoenix-Eco cells transfected with the pMXs-IG containing hRPE65 or hRPE65 (D477G) according to a previously published protocol (58) . Transduced cells were sorted by a FACSAria cell sorter (BD Biosciences, San Jose, CA) to selectively collect transduced cells and ensure comparable EGFP expression between NIH3T3-LRAT-hRPE65 and NIH3T3-LRAT-hRPE65 (D477G).
Cells were maintained in growth medium (GM) composed of Dulbecco's modified Eagle's medium (Gibco, Gaithersburg, MD), pH 7.2, with 4 mM L-glutamine, 4500 mg/l glucose and 110 mg/ l sodium pyruvate supplemented with 10% (v/v) heatinactivated fetal bovine serum, 100 units/ml penicillin and 100 units/ml streptomycin. After reaching confluence, cells were washed twice with PBS, trypsinized, passaged and then maintained at 37 C in 5% CO 2 .
Immunoblotting of RPE65 
Immunoprecipitation
Immunoprecipitation was performed with anti-ubiquitin antibody (Abcam) coupled to magnetic, protein G Dynabeads (Invitrogen). Total RPE cell extracts isolated from WT, heterozygous KI or homozygous KI mice (two eyes per genotype), prepared in RIPA buffer, were incubated with anti-ubiquitin antibody conjugated magnetic beads (1.5 mg beads and 12 mg antibody per reaction) for 20 min at room temperature under constant, mild agitation. The supernatant was then removed and kept for further analysis, and the beads were washed three times in PBS containing 0.1% (v/v) Tween-20 by gentle pipetting and subsequent removal of wash buffer. Proteins pulled down by the beads were eluted by incubation for 20 min in a room temperature Thermomixer (Eppendorf, Hauppauge, NY) at 300 rpm in 20 ml Elution Buffer (NuPAGE LDS sample buffer and NuPAGE sample reducing agent, mixed per manufacturer's instructions). The lysate, flow through and eluate were separated on a NuPAGE 4-12% Bis-Tris gel (Invitrogen). Immunoblotting was performed as described in the preceding section.
Immunocytochemistry
Cells were fixed with 4% (w/v) paraformaldehyde (ThermoFisher Scientific) for 10 min and permeabilized with PBST (PBS containing 0.1% Triton X-100) for 10 min. Then cells were blocked in PBST containing 5% goat serum at room temperature. Cells were immunostained with anti-RPE65 monoclonal antibody (1: 1000) and anti-Calnexin polyclonal antibody (1: 200) (Abcam) followed by the corresponding Alexa Fluor 647 anti-mouse IgG (1: 1000) (ThermoFisher Scientific), Alexa Fluor 594 anti-rabbit IgG (1: 1000) (ThermoFisher Scientific) and DAPI. Samples then were mounted in ProLong Gold antifade reagent (Invitrogen) and imaged with a Leica TCS SP8 confocal microscope.
Retinoid isomerization activity assay NIH3T3-LRAT-hRPE65 or NIH3T3-LRAT-hRPE65 (D477G) cells were plated in six-well culture plates at 0.8 Â 10 6 cells per well in GM. The isomerization reaction was initiated 16 h later by replacing GM with fresh GM containing 10 mM all-trans-retinol delivered in N, N-dimethylformamide. Cells shielded from light were maintained at 37 C in 5% CO 2 . After 16 h, cells and medium were collected, mixed with an equal volume of 4 M KOH in methanol and incubated at 52 C for 2.5 h to hydrolyze retinoid esters. Next, an equal volume of hexane was added, and the mixture was vigorously shaken. Following a 15 min centrifugation at 4000 rpm to facilitate phase separation, the organic phase was collected, dried in vacuo and dissolved in 250 ml of hexane. Extracted retinoids were separated on a normal phase HPLC column (Sil; 5 mm, 4.6 Â 250 mm; Agilent Technologies, Santa Clara, CA) equilibrated with 10% ethyl acetate in hexane at an isocratic flow rate of 1.4 ml/min. 11-cis-retinol was detected by its characteristic retention time and absorption spectrum and quantified by correlating peak areas to a standard curve.
Real-time PCR analysis
Total RNA from the RPE layer of WT, heterozygous KI and homozygous KI mice was isolated according to a previously published method (62) . cDNA was synthesized with a high capacity RNA-tocDNA kit (Applied Biosystems, Foster City, CA) following the manufacturer's instructions. The same amount of total RNA was processed without reverse transcriptase as a negative control. Real-time PCR was performed using iQ TM SYBR Green Supermix 
RPE65 cDNA fragment cloning
Total RNA from the RPE layer of WT, heterozygous KI and homozygous KI mice was isolated according to a previously published method (62) . cDNA was synthesized with a high capacity RNA-to-cDNA kit (Applied Biosystems, Foster City, CA) following the manufacturer's instructions. The same amount of total RNA was processed without reverse transcriptase as a negative control. PCR was performed using Phusion High-Fidelity PCR Master Mix with the following primers: forward, 5 0 -TATGAAGACAATGGATTTCTGATTGTGGATCTCTGTTGCT-3 0 ; reverse, 5 0 -ATGTTCAGGATCTTTTGAACAGTCCATGGAAGGTCA CAGG-3 0 . The 655-bp predicted PCR products were not generated by negative controls involving either non-reverse-transcribed total RNA or water as templates. After purification with a QIAquick PCR purification kit, PCR products were ligated into pCR 4Blunt-TOPO (Invitrogen) and transformed into One Shot Top10 Chemically Competent E. coli (Invitrogen). Sequencing was used to determine the presence of WT RPE65 and D477G RPE65 fragments (examples of sequence chromatograms from heterozygous KI animals are shown in Fig. 2C ). To examine the ratio of WT RPE65 and D477G RPE65 mRNA, 95 cDNA clones from two heterozygous KI mice were randomly selected and sequenced.
SLO and OCT imaging
Mice were anesthetized by intraperitoneal injection of a cocktail consisting of 20 mg/ml ketamine and 1.75 mg/ml xylazine in phosphate-buffered saline at a dose of 0.1-0.13 ml per 25 g body weight. Pupils were dilated with 1% tropicamide (Henry Schein, Melville, NY) before imaging. Heidelberg Retinal Angiograph II (Heidelberg Engineering, Franklin, MA) was used for whole fundus imaging of retinas in vivo. Ultra-high resolution spectral domain OCT (Bioptigen, Morrisville, NC) was employed for imaging of retinas in vivo. Five frames of OCT images were acquired in the Bmode and then used to construct final averaged images. For quantitative measurements, the thickness of the ONL was measured 0.50 mm away from the optic nerve head in the superior, inferior, temporal and nasal retina. These values were then averaged.
ERG
Prior to recording, mice were dark adapted for 24 h. Under a safety light, mice were anesthetized by intraperitoneal injection of a cocktail consisting of 20 mg/ml ketamine and 1.75 mg/ml xylazine in phosphate-buffered saline at a dose of 0.1-0.13 ml per 25 g body weight. Pupils were dilated with 1% tropicamide (Henry Schein), and then 2.5% hypromellose was applied to keep the corneas hydrated. Contact lens electrodes were placed onto the corneas, and reference and ground electrodes were positioned subdermally between the ears and on the tail, respectively. All ERGs were recorded with the universal testing and electrophysiological system UTAS E-3000 (LKC Technologies, Gaithersburg, MD). For single-flash scotopic ERG recording, the duration of white-light flash stimuli (from 20 ms to 1 ms) was adjusted to provide a range of illumination intensities from À3.7 to 2.3 log cdÁs/m 2 . For each intensity, 3 to 20 recordings were made at sufficient intervals between flash stimuli (from 3 to 90 s) to allow recovery from any photobleaching effects. The photopic ERG recordings were performed after bleaching at 1.4 log cdÁs/m 2 for 10 minutes. For photopic ERG, the cone response was measured at four different light intensities (À0.7 to 2.3 log cdÁs/m 2 ) in the presence of rod-desensitizing white-light background.
HPLC retinoid profiling
Eyes were enucleated from dark-adapted WT, heterozygous KI and homozygous KI mice and then homogenized in 10 mM sodium phosphate buffer, pH 8.0, containing 50% methanol (v/v) and 100 mM hydroxylamine. After 15 min of incubation at room temperature, 2 ml of 3 M sodium chloride was added. The resulting sample was extracted twice with 3 ml of ethyl acetate. Then, the combined organic phase was dried in vacuo and reconstituted in 400 ll of hexane. Extracted retinoids (100 ml) were separated on a normal phase HPLC column (Sil; 5 mm, 4.6 Â 250 mm; Agilent Technologies) equilibrated with a stepwise gradient of 0.6% ethyl acetate in hexane at an isocratic flow rate of 1.4 ml/ min for 17 min and 10% ethyl acetate in hexane at an isocratic flow rate of 1.4 ml/min for 25 min. Retinoids were detected by monitoring their absorbance at 325 nm and quantified based on correlations of their peak areas.
ACO/RPE65 chimera construct design
A chimeric ACO/RPE65 coding sequence was synthesized by replacing the nucleotides encoding residues 44-45, 431-442, 461 and 463 of Synechocystis ACO (GI: 81671293) with those encoding residues 36-37, 474-485, 506 and 508 of bovine RPE65 (GI: 27806125) (Genscript, Piscataway, NJ). The open reading frame was subcloned into the pET3a expression vector. The D434G point mutant (corresponding to D477G in RPE65 and referred to as such in the manuscript) was generated by the QuikChange site-directed mutagenesis protocol (Stratagene, San Diego, CA).
Coding regions of all expression plasmids were verified by sequencing.
ACO/RPE65 chimera expression, purification and crystallization ACO/RPE65 chimera and its D477G variant were expressed, purified and crystallized as described previously for ACO (36) with the following modifications. Protein expression was not chemically induced but instead relied on basal T7 promoter activity. Following purification, proteins were diluted into a buffer consisting of 20 mM HEPES-NaOH, pH 7 (Sigma-Aldrich) and 0.02% v/v Triton X-100 (Anatrace, Maumee, OH) to a final concentration of 10 mg/ml. Crystals were formed by the hanging-drop vapor diffusion method after mixing 2 ll drops of protein solution with 2 ll of a crystallant consisting of 0.1 M Bis-Tris propane, pH 6 (Sigma-Aldrich) and 21% w/v sodium polyacrylate 2100 (Molecular Dimensions, Maumee, OH). After 2-3 weeks of growth, crystals were cryoprotected in crystallant supplemented with 15% v/v ethylene glycol, flash cooled in liquid nitrogen and then stored in nitrogen vapor prior to X-ray exposure.
Diffraction data collection, structure solution and refinement Diffraction data were collected at the NSLS II AMX and FMX beamlines or the APS NECAT IDE beamline. Data reduction was carried out with XDS (63) . The ACO/RPE65 chimera structure, which was isomorphous to previous ACO structures (36, 37) , was solved by direct refinement in REFMAC (64) using the coordinates deposited under PDB accession code 4OU9 as a starting model. Amino acid replacements were performed with COOT (65) . The ACO/RPE65 chimera coordinates were used as a search model to solve the structures of the two D477G crystal forms by molecular replacement in the program Phaser (66) . Structural models were iteratively improved by manual real space refinement in COOT and reciprocal space refinement in REFMAC. Such models were periodically checked for geometric soundness and fit to the electron density maps with MOLPROBITY (67) and the wwPDB validation server (68) .
Structure analysis
CCO amino acid sequence alignments were carried out with Clustal Omega (69) and were annotated with Espript (70) . Structural motifs involving specific amino acid sequences were identified and analyzed with PDBeMotif using the MSDmotif algorithm (35) . Secondary structures and contact surfaces for the ACO/RPE65 chimera crystal structures were analyzed with PDBsum (30) and PISA (71) . Electrostatics calculations were carried out with APBS (72) . Figures displaying three-dimensional structures were rendered using PyMOL (Schrö dinger, LLC).
ACO/RPE65 chimera activity assays
Enzymatic activity of purified ACO and ACO/RPE65 proteins were assayed spectrophotometrically by monitoring formation of the all-trans-retinal product at 340 nm using all-trans-b-apo-8 0 -carotenol as the reaction substrate and assay conditions identical to those previously described (Supplementary Material, Fig. S3 ) (36) .
Statistics
Data representing the means 6 SEMs (unless otherwise indicated) are presented for results of at least three independent experiments. Significance between groups was determined either with the unpaired Student's t-test or one-way ANOVA with the Bonferroni post-test for comparisons of more than two groups. Sigma Plot 11.0 (Systat Software) was used to perform the statistical analyses.
Supplementary Material
Supplementary Material is available at HMG online.
